Involvement of NEK2 and its interaction with NDC80 and CEP250 in hepatocellular carcinoma.
Lu ZengXiude FanXiaoyun WangHuan DengXiaoge ZhangKun ZhangShan HeNa LiQunying HanZhengwen LiuPublished in: BMC medical genomics (2020)
NEK2 and its interacting proteins NDC80 and CEP250 play important roles in HCC development and progression and thus may be potentially used as biomarkers and therapeutic targets of HCC.
Keyphrases